Alpine Global Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-30,141
Closed -$382K 365
2024
Q2
$382K Buy
30,141
+19,916
+195% +$200K 0.07% 210
2024
Q1
$48.9K Buy
+10,225
New +$47.4K 0.01% 185
2023
Q1
Sell
-10,906
Closed -$112K 327
2022
Q4
$112K Buy
+10,906
New +$192K 0.04% 228
2020
Q4
Sell
-2,000
Closed -$217K 275
2020
Q3
$217K Buy
+2,000
New +$244K 0.05% 152

Other funds holding NVAX

Alpine Global Management's NVAX Position: Q3 2024 in Review

Alpine Global Management sold out of Novavax (NVAX) in Q3 2024, closing a stake of 30,141 shares — an estimated $382K sold.

Alpine Global Management first reported a position in NVAX in Q3 2020 and held it in 4 quarters. The position peaked at $382K in Q2 2024. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Alpine Global Management reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 30,141 Novavax shares in Q3 2024, an estimated $382K.
  • Alpine Global Management first reported a position in Novavax in Q3 2020 and held it in 4 quarters.
  • Alpine Global Management's Novavax position peaked at $382K in Q2 2024.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.